Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This could be the bottom. This is already a very deep adjustment
The key support area is 0.5~0.75. But I don't feel it could reach 0.5
Is next support level .84?
What is the definition for a subpenny stock? This one is already under one dollar!!!
Cheds,
I am not good at reading charts. Could you please point out the numbers for the key support area? Is it around 0.6? Or if it is a band, what is the upper and lower points for this band?
The hyper may not be over yet. Who knows
I simply posted what he said. Period.
Just one more note: The doctor is a physician instead of a foot specialist. Therefore, he deals problems in a wide area of medicine.
I contacted the doctor (info@viadermalicensing.com), asking about the news:
Dr. Chris Ayo Otiko, President of ViaDerma, Inc., is selected to write an article "Healing Diabetic Ulcers with a New Topical Antibiotic Ointment" for the Journal of Diabetes Science and Technology, a leading US Publication for Diabetes.
Then, I requested a copy of his paper. Since it is not published yet, he emailed me his draft. I am not in the field of medicine, there is no way for me to copy his ideas. Lol.
I have contacted the doctor to verify he is indeed invited to write a paper in that Journal. The doctor replied to me and send me the paper draft. However, because the paper is not published yet, I can't post it here for everybody's review. This is the protocol in the academic world. After the paper is published in the Journal, everybody will be able to see it.
The good thing is that the doctor has agreed to publish his poster in the conference, probably on his website. The main content in his conference poster, the draft, and the paper to be published in the Journal are the same.
I have received a copy of the draft for the paper presented in the conference, which is also the one that will be published in the Journal. Even though I am not a professional in medicine, I can see that this is a stringent academic study that can be presented in the Journal using the standard paper format required by the academic society.
I can't post the paper draft here for everybody's review due to copyright issues. However, I believe the doctor will have no problems in putting a copy of the paper here after it is official published.
Based on the statistics in 2015~2016, FDA almost approves all the drug applications ...
OWCP is heavily oversold now because of the previous days gap filling process ...
As a professional in a high-tech area, I know even a patented technology would only reveal limited details in public for reasons. O/W, others could make some very tiny improvement and make profits
Nobody would give out the formula just in case somebody else copy the procedure to make profits
If this doctor didn't work on medicine last year, how could this happen:
http://www.morningstar.com/news/marketwired/MWR_urn:newsml:marketwired.com:20020408:2017020911G129813-001_US/dr-chris-ayo-otiko-president-of-viaderma-inc-is-selected-to-write-an-article-healing-diabetic-ulcers-with-a-new-topical-antibiotic-ointment-for-the-journal-of-diabetes-science-and-technology-a-leading-us-publication-for-diabetes.print.html
Not everybody in the professional circle could have such an honor.
It can go up a lot tomorrow when people see the news here
I wouldn't look much into any details of the testing data even if everything is publish because this could be very professional and may not make any sense to me based on my professional level in medicine. Besides, if I were the company, I would prefer to keep most of the details inside the company just in case somebody copies (or makes very tiny changes on) the procedure and make profits form it.
Many people don't know this news yet. It takes time
The news is not on this message board yet. Currently, the newest one is the one on Mar. 20.
This one could be big!
It could be around 1.2 today because it is also oversold!
Many people may not know the news yet ...
Maybe this is kind of a silly question. But, what is PR?
Don't know if we could shoot up to be around $10 this time since Axim was from $0.45 ~ $6 for efficacy study done
We are at a very similar point when AXIM finished its efficacy test (stock price from $0.45 to $6). Next step for OWCP would be test on human (in hospital) which is similar to AXIM's clinical test (stock price from $8 to $19.8).
Very exciting moment now!
last 8k (Feb. 24) only has 90% efficacy test done and no IRB (extended one) test yet. So everybody simply waited for the complete efficacy study (100%) to be done. There is a huge difference here.
Next step would be the test on human (in hospital). Then the product will be out on market!
And with no side effect!
So, OWCP has finished both efficacy study and the extended test (IRB test), and the result is significant (70% improvement). OWCP is currently working on protecting their IP. After that, they may be able to give out more data on their work. Am I right?
I guess these data they are considering to give out after IP protection must be very professional, and I doubt how many people could understand this part.
To me, this 8k might be enough to know OWCP current status on the work. I wouldn't jump into more details because it is too professional
We usually couldn't get all the data details on a high-tech product due to IP protection. On the data sheet of a product, there could be some black boxes that we could only see the interfaces. The company will never ever reveal what is hiding inside these black boxes.
Such operations from high technology companies are very common. Otherwise, other companies could simply copy their procedure or results, then make some tiny changes based on their work. Then, make huge profits.
Any requests for all the details related to the product could be unreasonable, or could be considered as a violation of the IP protection law.
One thing important is that this stock is heavily OVERSOLD after so many red days. Besides, the gap at 0.92 is finally filled through today's run.
Checking price gaps for OWCP, looking back 1 year(s):
OWCP: last price is $0.969; period high is $3.23
Gap Date Days Passed Gap Price Decline needed High Retrace Fibo±.02
2016-12-23 73 0.12 -87.1% 0.039 --
19 total gaps; 18 filled; 1 not filled.
(No one would think this 0.12 gap will be filled)
I am expecting a bounce even without news.
I have added 40k while OWCP moved down during these days. Not the best deal, but the safest way to take care the situation. This delay of report actually gave us a very good opportunity to buy more. Buy at dip and sell at high because OWCP is good and strong! This is the key to make profits in a stock market
People who didn't get in today may regret while seeing good news here.
It may bounce back up to be over one dollar today. Everybody knows the value of this company, and there could be a lot of funds trying to make the best use of this gap filling opportunity.
But the gap checker still says it is not filled?
It is going down very slowly because many people are trying to add in this range ...
All my orders are above .90, and I don't think it could go to .80s.
I have some additional orders around .92 as well. I have actually added shares at different price points along the way it went done, just in case $OWCP couldn't go done this far to .92. This is a very good company that definitely worth investment in the long run! This is the excellent opportunity to add shares!
There is another gap at .12, but nobody would think it needs to be filled. $OWCP will bounce back up!
Checking price gaps for OWCP, looking back 1 year(s):
OWCP: last price is $1.01; period high is $3.23
Gap Date Days Passed Gap Price Decline needed High Retrace Fibo±.02
2016-12-23 72 0.12 -87.6% 0.039 --
2017-02-21 30 0.92 -9.4% 0.283 --
19 total gaps; 17 filled; 2 not filled.
You can check the gap here:
http://to.pythonanywhere.com/gapcheck